Terms: = Leukemia AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51 AND Treatment
110 results:
1. Uptake of novel therapies into first-line treatment for acute myeloid leukemia patients: EU4 + UK perspective.
Ruiz M; Jindal K; Casey V; Soares LM; Manuguid F; Moehler T
Future Oncol; 2024 Mar; 20(9):533-546. PubMed ID: 37975244
[TBL] [Abstract] [Full Text] [Related]
2. Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings.
Rossi G; Salmanton-García J; Cattaneo C; Marchesi F; Dávila-Valls J; Martín-Pérez S; Itri F; López-García A; Glenthøj A; Gomes da Silva M; Besson C; Marchetti M; Weinbergerová B; Jaksic O; Jiménez M; Bilgin YM; Van Doesum J; Farina F; Žák P; Verga L; Collins GP; Bonuomo V; Van Praet J; Nucci M; Meers S; Espigado I; Fracchiolla NS; Valković T; Poulsen CB; Čolović N; Dragonetti G; Ledoux MP; Tascini C; Buquicchio C; Blennow O; Passamonti F; Machado M; Labrador J; Duarte RF; Schönlein M; Prezioso L; Falces-Romero I; Kulasekararaj A; Garcia-Vidal C; Fernández N; Abu-Zeinah G; Ormazabal-Vélez I; Adžić-Vukičević T; Piukovics K; Stoma I; Cuccaro A; Magliano G; Szotkowski T; González-López TJ; El-Ashwah S; Bergantim R; Sili U; Maertens J; Demirkan F; De Ramón C; Petzer V; Del Principe MI; Navrátil M; Dargenio M; Seval GC; Samarkos M; Ráčil Z; Pinczés LI; Lahmer T; Busca A; Méndez GA; Vena A; Biernat MM; Merelli M; Calbacho M; Barać A; Bavastro M; Limongelli A; Ilhan O; Wolf D; Çolak GM; García-Sanz R; Emarah Z; Mišković B; Gräfe SK; Mladenović M; Aiello TF; Núñez-Martín-Buitrago L; Nordlander A; Arellano E; Zambrotta GPM; Ammatuna E; Cabirta A; Sacchi MV; Nunes Rodrigues R; Hersby DS; Hanakova M; Rahimli L; Cordoba R; Cornely OA; Pagano L;
Int J Infect Dis; 2023 Dec; 137():98-110. PubMed ID: 37863310
[TBL] [Abstract] [Full Text] [Related]
3. miR-603 promotes cell proliferation and differentiation by targeting TrkB in acute promyelocytic leukemia.
Li H; Hou J; Fu Y; Zhao Y; Liu J; Guo D; Lei R; Wu Y; Tang L; Fan S
Ann Hematol; 2023 Dec; 102(12):3357-3367. PubMed ID: 37726492
[TBL] [Abstract] [Full Text] [Related]
4. A small molecule bcl6 inhibitor as chemosensitizers in acute myeloid leukemia.
Zhang L; Wu M; Guo W; Zhu S; Li S; Lv S; Li Y; Liu L; Xing Y; Chen H; Liu M; Peng S; Chen Y; Yi Z
Biomed Pharmacother; 2023 Oct; 166():115358. PubMed ID: 37634473
[TBL] [Abstract] [Full Text] [Related]
5. The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas.
Salaverria I; Weigert O; Quintanilla-Martinez L
Blood Adv; 2023 Sep; 7(18):5258-5271. PubMed ID: 37561599
[TBL] [Abstract] [Full Text] [Related]
6. Neurocognitive outcomes in adult survivors of neuroblastoma: A report from the Childhood Cancer Survivor Study.
Hesko C; Liu W; Srivastava DK; Brinkman TM; Diller L; Gibson TM; Oeffinger KC; Leisenring WM; Howell R; Armstrong GT; Krull KR; Henderson TO
Cancer; 2023 Sep; 129(18):2904-2914. PubMed ID: 37199722
[TBL] [Abstract] [Full Text] [Related]
7. Patterns of Diagnostic Evaluation and Determinants of treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes.
Mukherjee S; Dong W; Schiltz NK; Stange KC; Cullen J; Gerds AT; Carraway HE; Singh A; Advani AS; Sekeres MA; Koroukian SM
Oncologist; 2023 Oct; 28(10):901-910. PubMed ID: 37120291
[TBL] [Abstract] [Full Text] [Related]
8. CHANGES ANALYSIS OF THE HEPATOCYTE APOPTOSIS MARKERS LEVELS IN MALIGNANT OBSTRUCTIVE JAUNDICE COMPLICATED BY CHOLANGITIS.
Dronov OI; Kovalska IO; Kozachuk YS; Levchenko LV; Vlasenko DA; Shvets AS
Wiad Lek; 2023; 76(3):560-567. PubMed ID: 37057780
[TBL] [Abstract] [Full Text] [Related]
9. The Health Care Utilization and Medical Costs in Long-Term Follow-Up of Children Diagnosed With leukemia, Solid Tumor, or Brain Tumor: Population-Based Study Using the National Health Insurance Claims Data.
Miser JS; Shia BC; Kao YW; Liu YL; Chen SY; Ho WL
JMIR Public Health Surveill; 2023 Mar; 9():e42350. PubMed ID: 36862495
[TBL] [Abstract] [Full Text] [Related]
10. The Immuno-Oncology and Genomic Aspects of DNA-Hypomethylating Therapeutics in Acute Myeloid leukemia.
Urabe A; Chi S; Minami Y
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835136
[TBL] [Abstract] [Full Text] [Related]
11. A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea.
Jo JC; Jeon Y; Kim D; Yang DH; Lee WS; Choi YS; Yi JH; Yoon DH; Kong JH; Choe JY; Kim S; Ahn K; Park T; Ju H; Kwon S; Cho SG
Expert Opin Biol Ther; 2023; 23(8):737-747. PubMed ID: 36757373
[TBL] [Abstract] [Full Text] [Related]
12. Interferon gamma regulates a complex pro-survival signal network in chronic lymphocytic leukemia.
Chen Y; Shao X; Yang H; Ren L; Cui Y; Zhang W; Macip S; Meng X
Eur J Haematol; 2023 Apr; 110(4):435-443. PubMed ID: 36576398
[TBL] [Abstract] [Full Text] [Related]
13. Fibrillary and immunotactoid glomerulopathies in the Hunter region: a retrospective cohort study.
Cohen AWS; Vilayur E
Intern Med J; 2023 Oct; 53(10):1837-1845. PubMed ID: 36305476
[TBL] [Abstract] [Full Text] [Related]
14. B-cell Lymphoma 6 (bcl6): From Master Regulator of Humoral Immunity to Oncogenic Driver in Pediatric Cancers.
McLachlan T; Matthews WC; Jackson ER; Staudt DE; Douglas AM; Findlay IJ; Persson ML; Duchatel RJ; Mannan A; Germon ZP; Dun MD
Mol Cancer Res; 2022 Dec; 20(12):1711-1723. PubMed ID: 36166198
[TBL] [Abstract] [Full Text] [Related]
15. HHV8-negative primary effusion-based large B-cell lymphoma in a patient with chronic myeloid leukemia, BCR::ABL1-positive under dasatinib treatment: Report of a new case and literature review.
Christe L; Veloza L; Gros L; Bisig B; Blum S; Hewer E; de Leval L
Diagn Cytopathol; 2022 Dec; 50(12):E351-E356. PubMed ID: 35916333
[TBL] [Abstract] [Full Text] [Related]
16. Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement.
Bomken S; Enshaei A; Schwalbe EC; Mikulasova A; Dai Y; Zaka M; Fung KTM; Bashton M; Lim H; Jones L; Karataraki N; Winterman E; Ashby C; Attarbaschi A; Bertrand Y; Bradtke J; Buldini B; Burke GAA; Cazzaniga G; Gohring G; De Groot-Kruseman HA; Haferlach C; Nigro LL; Parihar M; Plesa A; Seaford E; Sonneveld E; Strehl S; Van der Velden VHJ; Rand V; Hunger SP; Harrison CJ; Bacon CM; Van Delft FW; Loh ML; Moppett J; Vormoor J; Walker BA; Moorman AV; Russell LJ
Haematologica; 2023 Mar; 108(3):717-731. PubMed ID: 35484682
[TBL] [Abstract] [Full Text] [Related]
17. Utility of the treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation.
Zarling LC; Othus M; Sandmaier BM; Milano F; Schoch G; Davis C; Bleakley M; Deeg HJ; Appelbaum FR; Storb R; Walter RB
Leukemia; 2022 Jun; 36(6):1563-1574. PubMed ID: 35440690
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic value of low-level MRD in adult acute lymphoblastic leukemia detected by low- and high-throughput methods.
Kotrová M; Koopmann J; Trautmann H; Alakel N; Beck J; Nachtkamp K; Steffen B; Raffel S; Viardot A; Wethmar K; Darzentas N; Baldus CD; Gökbuget N; Brüggemann M
Blood Adv; 2022 May; 6(10):3006-3010. PubMed ID: 35026836
[TBL] [Abstract] [Full Text] [Related]
19. FX1, a bcl6 inhibitor, reactivates bcl6 target genes and suppresses HTLV-1-infected T cells.
Ishikawa C; Mori N
Invest New Drugs; 2022 Apr; 40(2):245-254. PubMed ID: 34698964
[TBL] [Abstract] [Full Text] [Related]
20. Gilteritinib-induced upregulation of S100A9 is mediated through bcl6 in acute myeloid leukemia.
Zavorka Thomas ME; Jeon JY; Talebi Z; Buelow DR; Silvaroli J; Campbell MJ; Sparreboom A; Pabla N; Baker SD
Blood Adv; 2021 Dec; 5(23):5041-5046. PubMed ID: 34614509
[TBL] [Abstract] [Full Text] [Related]
[Next]
